SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta‐analysis

SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta‐analysis

Abstract Aims This study aimed to determine the effects of sodium‐glucose cotransporter‐2 inhibitor (SGLT2i) in heart failure with reduced ejection fraction (HFrEF), compare the effect of SGLT2i with angiotensin receptor neprilysin inhibitor (ARNI), and find whether combination of SGLT2i and ARNI is...

Full description

Bibliographic Details
Main Authors: Yuling Yan, Bin Liu, Jun Du, Jing Wang, Xiaodong Jing, Yajie Liu, Songbai Deng, Jianlin Du, Qiang She
Format: Article
Language:English
Published: Wiley 2021-06-01
Series:ESC Heart Failure
Subjects:
Sodium‐glucose cotransporter‐2 inhibitor
Angiotensin receptor neprilysin inhibitor
Heart failure with reduced ejection fraction
Meta‐analysis
Online Access:https://doi.org/10.1002/ehf2.13313

Internet

https://doi.org/10.1002/ehf2.13313

Similar Items